Development and validation of a quantitative method for thymidine phosphorylase activity in peripheral blood mononuclear cells-Reference-Cited by-同舟云学术

Development and validation of a quantitative method for thymidine phosphorylase activity in peripheral blood mononuclear cells

Published:2018-08-03 Issue:8 Volume:37 Page:436-454
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides and Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides and Nucleic Acids

Author:

Jacobs Bart A.W.¹²,Pluim Dick¹,van der Laan Pia¹,Tzani Anna¹,Beijnen Jos H.¹²³,Schellens Jan H.M.¹³

Affiliation:

1. Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;

2. Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, The Netherlands;

3. Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmaco-epidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands

Publisher

Informa UK Limited

Subject

Genetics,Molecular Medicine,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15257770.2018.1498270

Reference36 articles.

1. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

2. Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.

3. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

4. BIOACTIVATION OF CAPECITABINE IN HUMAN LIVER: INVOLVEMENT OF THE CYTOSOLIC ENZYME ON 5′-DEOXY-5-FLUOROCYTIDINE FORMATION

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I pharmacological study of continuous chronomodulated capecitabine treatment;Pharmaceutical Research;2020-05